Combining Fulvestrant (Faslodex™) with Continued Oestrogen Suppression in Endocrine-sensitive Advanced Breast Cancer: the SoFEA Trial

Combining Fulvestrant (Faslodex™) with Continued Oestrogen Suppression in Endocrine-sensitive Advanced Breast Cancer: the SoFEA Trial

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Oncology - Volume 20, Issue 5, June 2008, Pages 321-324

D. Dodwell, G. Coombes, J.M. Bliss, L.S. Kilburn, S. Johnston, on behalf of the SoFEA Trial Management Group on behalf of the SoFEA Trial Management Group,